The XS106 cell: a Langerhans' cell surrogate with a selective type 2 phenotype

Area of Science:

• Immunology
• Dermatology
• Cell Biology

Background:

• Epidermal Langerhans' cells (LC) are crucial for initiating and regulating skin immune responses.
• Studying LC ex vivo is challenging due to their low frequency (less than 3% of epidermal cells).

Purpose of the Study:

• To evaluate the XS106 cell line, a mouse epidermal dendritic cell (DC) line, as a suitable surrogate for studying LC.
• To characterize XS106 cells' membrane marker expression, chemokine production, and migration patterns.

Main Methods:

• Treatment of XS106 cells with various toll-like receptor (TLR) ligands.
• Comparison of XS106 cells with mouse bone marrow-derived DCs (BMDC) and ex vivo LC.
• Analysis of membrane marker expression, chemokine secretion, and migratory responses.

Main Results:

• XS106 cells express generic DC markers and higher levels of skin DC markers than BMDC.
• XS106 cells and LC-enriched fractions exhibit higher constitutive expression of type 2-associated chemokines than type 1.
• Type 2 TLR ligands, but not type 1, increased MHC class II and co-stimulatory molecule expression on XS106 cells; type 1 TLR ligands did not induce selective type 1 chemokine secretion.
• XS106 cells migrated in response to chemokines known to attract LC.

Conclusions:

• XS106 cells exhibit functional and phenotypic similarities to epidermal Langerhans' cells (LC).
• The XS106 cell line serves as a valuable in vitro model for studying LC due to its selective type 2 polarization and migration characteristics.